Gamida Cell (NASDAQ:GMDA – Get Rating) and Passage Bio (NASDAQ:PASG – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, dividends, analyst recommendations, institutional ownership and profitability. Insider and Institutional Ownership 53.4% of Gamida Cell shares […]